Allostatic load, personality traits, and cancer risk: A prospective cohort study.
[BACKGROUND] Cumulative stress exposure is extensively involved in carcinogenesis.
- 95% CI 1.05-1.23
- HR 1.14
- 추적기간 13.5 years
- 연구 설계 cohort study
APA
Wang P, Peng Y, et al. (2026). Allostatic load, personality traits, and cancer risk: A prospective cohort study.. Psychological medicine, 56, e7. https://doi.org/10.1017/S0033291725102924
MLA
Wang P, et al.. "Allostatic load, personality traits, and cancer risk: A prospective cohort study.." Psychological medicine, vol. 56, 2026, pp. e7.
PMID
41486949
Abstract
[BACKGROUND] Cumulative stress exposure is extensively involved in carcinogenesis. However, cancer risk associated with allostatic load (AL), a valid measure of chronic stress, has not been comprehensively evaluated in large cohorts, and the combined effect of AL and personality trait on cancer risk remains unknown.
[METHODS] This prospective cohort study was conducted based on 245,683 participants from the UK Biobank, with a median follow-up of 13.5 years. The AL score was calculated based on 11 biomarkers. Personality traits were constructed and categorized into two clusters. Multivariable Cox regression model was used to assess the risk of incident cancer according to AL and personality clusters, and multiplicative and additive interactions were evaluated.
[RESULTS] High AL was associated with an increased cancer risk compared to low AL (hazard ratio [HR] = 1.06, 95% confidence interval [CI]: 1.04-1.09), particularly for cancers of stomach, liver, kidney, esophageal, lung, colorectal, breast, and leukemia (HR ranged from 1.08 to 1.43). Personality clusters was associated with risk of lung cancer (HR = 1.14, 95% CI: 1.05-1.23), but not overall cancer. Significant synergistic interaction was observed between high AL and 'nervous-dominant' personality for overall cancer risk, with the strongest association observed for liver cancer (HR = 1.58, 95% CI: 1.24-2.02).
[CONCLUSIONS] High AL was related to higher risks of overall cancer and site-specific cancers, particularly when combined with nervous-dominant personality, highlighting the interplay between chronic physiological stress and psychological factors in cancer development.
[METHODS] This prospective cohort study was conducted based on 245,683 participants from the UK Biobank, with a median follow-up of 13.5 years. The AL score was calculated based on 11 biomarkers. Personality traits were constructed and categorized into two clusters. Multivariable Cox regression model was used to assess the risk of incident cancer according to AL and personality clusters, and multiplicative and additive interactions were evaluated.
[RESULTS] High AL was associated with an increased cancer risk compared to low AL (hazard ratio [HR] = 1.06, 95% confidence interval [CI]: 1.04-1.09), particularly for cancers of stomach, liver, kidney, esophageal, lung, colorectal, breast, and leukemia (HR ranged from 1.08 to 1.43). Personality clusters was associated with risk of lung cancer (HR = 1.14, 95% CI: 1.05-1.23), but not overall cancer. Significant synergistic interaction was observed between high AL and 'nervous-dominant' personality for overall cancer risk, with the strongest association observed for liver cancer (HR = 1.58, 95% CI: 1.24-2.02).
[CONCLUSIONS] High AL was related to higher risks of overall cancer and site-specific cancers, particularly when combined with nervous-dominant personality, highlighting the interplay between chronic physiological stress and psychological factors in cancer development.
MeSH Terms
Humans; Allostasis; Male; Female; Prospective Studies; Neoplasms; Personality; Middle Aged; United Kingdom; Aged; Stress, Psychological; Risk Factors; Adult; Proportional Hazards Models
같은 제1저자의 인용 많은 논문 (5)
- Application progress of tRNA modification in gynecological tumors: A review.
- Integrated analysis and functional validation reveal KCNQ1 tumor suppressor targeting by dahuang Zhechong Pills via cuproptosis modulation in colorectal cancer.
- siRNA Nanoparticle Delivery Strategies and Clinical Trial Advances in Tumor Therapy.
- Retraction notice to "A chitosan-camouflaged nanomedicine triggered by hierarchically stimuli to release drug for multimodal imaging-guided chemotherapy of breast cancer" [Carbohydrate Polymers 335 (2024) 122073].
- Succinylated D-Type Neuropeptide Integrated with Iron-Based Probes for Regulating Mitochondrial Function and Homeostasis in Breast Cancer.